Moreover, NF-κB pathway inhibition can block the proliferation and survival of DLBCL and MM cell lines that have chronic activation of NF-κB in a variety of in vitro cell and in vivo mouse models [15,16]. The gene discussed is NFKB1; the disease is Miyoshi myopathy.